BioRestorative Therapies, Inc. Share Price
Equities
BRTX
US0906556065
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 USD | -6.85% | +8.80% | -21.83% |
Sales 2024 * | 60K 4.78M | Sales 2025 * | 60K 4.78M | Capitalization | 9.88M 787M |
---|---|---|---|---|---|
Net income 2024 * | -17M -1.35B | Net income 2025 * | -20M -1.59B | EV / Sales 2024 * | 165 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 165 x |
P/E ratio 2024 * |
-0.69
x | P/E ratio 2025 * |
-0.69
x | Employees | 11 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.2% |
1 day | +6.57% | ||
1 week | +18.70% | ||
Current month | +2.82% | ||
1 month | +9.77% | ||
3 months | -47.86% | ||
6 months | -18.93% | ||
Current year | -16.09% |
Managers | Title | Age | Since |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 30/09/18 |
Robert Kristal
DFI | Director of Finance/CFO | - | 03/11/21 |
Compliance Officer | 55 | 31/08/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 28/10/21 |
David Rosa
BRD | Director/Board Member | 59 | 28/10/21 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 12/04/11 |
Date | Price | Change | Volume |
---|---|---|---|
03/05/24 | 1.36 | -6.85% | 66 419 |
02/05/24 | 1.46 | +6.57% | 363,272 |
01/05/24 | 1.37 | -3.52% | 1,165,569 |
30/04/24 | 1.42 | +14.52% | 16,816,488 |
29/04/24 | 1.24 | -0.80% | 32,272 |
Delayed Quote Nasdaq, May 02, 2024 at 09:30 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.09% | 9.88M | |
-1.65% | 103B | |
+6.75% | 101B | |
+6.58% | 23.07B | |
-12.60% | 22.23B | |
-5.48% | 18.05B | |
-39.98% | 17.18B | |
-10.17% | 16.94B | |
+6.12% | 14.07B | |
+35.47% | 12.35B |
- Stock Market
- Equities
- BRTX Stock